A comprehensive view of hospital / clinical drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
Published: April 26, 2024 by Bristol-Myers Squibb Co.
Executive Perspective: AstraZeneca CEO Pascal Soriot defends recent spate of acquisitions, arguing they're vital for future growth; Soriot says the deals aim to create synergy between oncology, vaccines, and respiratory disease products
Published: April 25, 2024 by FiercePharma
Bristol Myers Squibb reports first quarter financial results for 2024
Published: April 25, 2024 by Bristol-Myers Squibb Co.
Par Pharmaceutical expands recall to include seven lots of Treprostinil Injection 20mg/20mL due to the possibility of silicone particulates in the product; affected product is distributed in 20mL multidose vials as sterile solutions in water for injection
Published: April 23, 2024 by PR Newswire
INTERNATIONAL PATENT: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS EYE AND EAR INFIRMARY, BANNER HEALTH FILES APPLICATION FOR "COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE"
Published: April 23, 2024 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count